| Literature DB >> 22917957 |
Alexander I Klimov1, Rebecca Garten, Colin Russell, Ian G Barr, Terry G Besselaar, Rod Daniels, Othmar G Engelhardt, Gary Grohmann, Shigeyuki Itamura, Anne Kelso, John McCauley, Takato Odagiri, Derek Smith, Masato Tashiro, Xiyan Xu, Richard Webby, Dayan Wang, Zhiping Ye, Shu Yuelong, Wenqing Zhang, Nancy Cox.
Abstract
In February and September each year the World Health Organisation (WHO) recommends influenza viruses to be included in influenza vaccines for the forthcoming winters in the Northern and Southern Hemispheres respectively. These recommendations are based on data collected by National Influenza Centres (NIC) through the Global Influenza Surveillance and Response System (GISRS) and a more detailed analysis of representative and potential antigenically variant influenza viruses from the WHO Collaborating Centres for Influenza (WHO CCs) and Essential Regulatory Laboratories (ERLs). This article provides a detailed summary of the antigenic and genetic properties of viruses and additional background data used by WHO experts during development of the recommendations for the 2012 Southern Hemisphere influenza vaccine composition. Published by Elsevier Ltd.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22917957 PMCID： PMC6061925 DOI： 10.1016/j.vaccine.2012.07.089
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641